Mucus Clearance Devices Market Size, Share, and Industry Analysis, By Product Type (OPEP, Devices, PEP Devices, HFCWO Devices, IPV Devices, Mechanical Insufflation-Exsufflation (MI-E) Devices, and Others), By Application (COPD, Cystic Fibrosis, Asthma, Bronchiectasis, Neuromuscular Disorders, and Others), By End-user (Hospitals, Homecare Settings, Specialty Clinics, and Others), and Regional Forecast 2026-2034

The mucus clearance devices market size was valued at USD 711.3 million in 2025 and is expected to reach a market valuation of USD 748.1 million in 2026. Furthermore, the market is projected to reach a market valuation of USD 1,120.4 million by 2034, exhibiting a CAGR of 5.2% during the forecast period.

The market growth is attributed to growing burden of respiratory diseases and greater clinical use of mucus clearance devices in secretion-management pathways. Also, in neuromuscular diseasemechanical insufflation-exsufflation is being used to aid secretion clearance and help prevent respiratory complications and hospitalizations.

Mucus Clearance Devices Market Driver

Rising Prevalence of Respiratory Diseases to Drive the Market Growth

Over the past few years, there has been an increasing prevalence of COPD, asthma, bronchiectasis, cystic fibrosis, and related mucus-retention conditions. This is driving the demand for airway clearance as a core part of management, increasing adoption of mucus clearance devices. Such a scenario is anticipated to drive the market expansion.

• For instance, in June 2024, the Center for Disease Control and Prevention (CDC) stated that 16.0 million U.S. adults had COPD.

[[eABEcni7kU]

According to data from the Asthma and Allergy Foundation of America, in the U.S., more than 28.0 million individuals, roughly 1 in 12, live with asthma as of 2026.

Mucus Clearance Devices Market Restraint

High Device Cost for Advanced Systems to Hamper the Market Growth

Despite high demand for mucus clearance devices, premium technologies such as HFCWO vests and mechanical insufflation-exsufflation systems can be expensive, which is expected to slow their adoption, especially in cost-sensitive markets and smaller care settings. Additionally, the coverage requirements also add friction to adoption, which is anticipated to hamper the market expansion.

Mucus Clearance Devices Market Opportunity

Expansion in Neuromuscular Disorders to Offer Lucrative Growth Opportunity

In recent years, neuromuscular disorders have presented significant opportunities for mucus clearance devices, especially for MI-E devices, as secretion clearance and cough augmentation are clinically important in ALS, muscular dystrophy, spinal muscular atrophy, and related conditions. Moreover, the increasing incidence of such disorders is further supporting the demand for mucus clearance devices.

• For instance, according to data published by the National Center for Biotechnology Information (NCBI) in February 2024, muscular dystrophy remains a relatively rare disorder, affecting roughly 1 in 5,000 to 10,000 people globally.

Segmentation

Key Insights

The report covers the following key insights:

• Prevalence of Key Diseases, By Key Countries/Region, 2025
• Regulatory & Reimbursement Scenario
• Key Industry Developments - (Partnerships, Mergers, and Acquisitions, etc.)

Analysis by Product Type

By product type, the market is segmented into OPEP devices, PEP devices, HFCWO devices, IPV devices, mechanical insufflation-exsufflation (MI-E) devices, and others.

The OPEP devices segment is expected to hold the major share of the global market during the forecast period. The growth is attributed to higher adoption in homecare settings due to portability and ease of use, as well as its greater use in COPD, bronchiectasis, and cystic fibrosis. Furthermore, it requires less training than advanced systems.

Analysis by Application

By application, the market is segmented into COPD, cystic fibrosis, asthma, bronchiectasis, neuromuscular disorders, and others.

The COPD segment is expected to hold the major share of the global market during the forecast period. The growth is attributed to a higher patient pool globally among respiratory diseases due to a large number of aged individuals and smokers.

• For instance, according to the data from American Lung Association, approximately 11.1 million adults were living with COPD in the U.S. in 2023.

Analysis by End-user

Based on end-user, the market is divided into hospitals, homecare settings, specialty clinics, and others.

The homecare settings segment is expected to hold the largest share of the global market during the forecast period. The growth is attributed to shift toward long-term disease management at home as it reduces hospital visits and healthcare costs. As a result, there has been an increasing number of devices such as OPEP and HFCWO for home use.

Regional Analysis

Request for Customization   to gain extensive market insights.

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for a 39.0% share of the global mucus clearance devices market in 2025. The growth is supported by strong homecare adoption, better access to durable medical equipment, and established reimbursement pathway.

Asia Pacific is expected to grow at the highest CAGR during the forecast period. The growth is fueled by large respiratory disease burden, improving healthcare infrastructure, rising awareness, and expanding access to respiratory care in countries such as China, India, and Japan.

• For instance, according to the Global Asthma Report 2022, around 35.0 million Indians were suffering from asthma.

Key Players Covered

The global mucus clearance devices market is moderately consolidated, with presence of established and emerging players due to their strong portfolios and distribution networks.

The report includes the profiles of the following key players

• Monaghan Medical Corp (U.S.)
• ICU Medical, Inc. (U.S.)
• PARI Respiratory Equipment, Inc. (Germany)
• Baxter (U.S.)
• Electromed, Inc. (U.S.)
• ABM Respiratory Care (U.S.)
• Breas Medical AB (Sweden)
• Sentec AG (Switzerland)
• Better Breathing Devices (U.S.)
• Mercury Medical (U.S.)

Key Industry Developments

• January 2023: ABM Respiratory Care received FDA 510(k) clearance for its BiWaze Clear System, an airway clearance device using Oscillating Lung Expansion (OLE) therapy to clear airways and treat atelectasis.
• December 2021: Life Wellness Healthcare relaunched the AirPhysio OPEP mucus-clearance and lung-expansion device for daily asthma symptom management on its online store.